|
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
RECRUITINGN/ASponsored by Medtronic Cardiovascular
Actively Recruiting
PhaseN/A
SponsorMedtronic Cardiovascular
Started2026-09-11
Est. completion2031-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations13 sites
View on ClinicalTrials.gov →
NCT07321899
Summary
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age ≥18 years at the time of consent. * Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT). * Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR. Exclusion Criteria: * Any tricuspid device currently in place. * Anatomic contraindications. * Need for emergent or urgent surgery. * Left ventricular ejection fraction \<25%.
Conditions2
Heart DiseaseSevere Tricuspid Regurgitation
Locations13 sites
University of Alabama at Birmingham (UAB) Hospital
Abrazo Arizona Heart Hospital
Los Robles Hospital & Medical Center
Emory University Hospital Midtown
Find trials near these locations
Heart Disease trials in PhoenixHeart Disease trials in AtlantaHeart Disease trials in ChicagoHeart Disease trials in MinneapolisHeart Disease trials in New YorkHeart Disease trials in ClevelandAll trials in AlabamaAll trials in ArizonaAll trials in CaliforniaAll trials in ConnecticutAll trials in GeorgiaAll trials in IllinoisAll trials in MinnesotaAll trials in New YorkAll trials in Ohio
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMedtronic Cardiovascular
Started2026-09-11
Est. completion2031-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations13 sites
View on ClinicalTrials.gov →
NCT07321899